Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2,4-dione derivatives: Histone deacetylases inhibitory activity and molecular docking study
Abdelrahman Hamdi, Walaa M. El-Husseiny, Dina I. A. Othman, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114827-114827
Closed Access | Times Cited: 22

Showing 22 citing articles:

Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies
Dina I. A. Othman, Abdelrahman Hamdi, Samar S. Tawfik, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 40
New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study
Mohammad M. Al‐Sanea, Abdelrahman Hamdi, Ahmed A. B. Mohamed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 29
Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study
Noura F.M. El Hamaky, Abdelrahman Hamdi, Waleed A. Bayoumi, et al.
Bioorganic Chemistry (2024) Vol. 148, pp. 107437-107437
Closed Access | Times Cited: 13
Curriculum vitae of HDAC6 in solid tumors
Yi‐Chao Zheng, Huiqin Kang, Bo Wang, et al.
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123219-123219
Closed Access | Times Cited: 18
Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
Sk. Abdul Amin, Samima Khatun, Shovanlal Gayen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115594-115594
Closed Access | Times Cited: 17
Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights
Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A. Ewes, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 16
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study
Samar S. Tawfik, Abdelrahman Hamdi, Ahmed R. Ali, et al.
RSC Advances (2024) Vol. 14, Iss. 36, pp. 26325-26339
Open Access | Times Cited: 5
Remarkable utilization of quinazoline-based homosulfonamide for in vitro cytotoxic effects with triple kinase inhibition activities: cell cycle analysis and molecular docking profile
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Ahmed H. Bakheit, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 541-558
Open Access
Technologies of targeting histone deacetylase in drug discovery: Current progress and emerging prospects
Jinxiao Ru, Yuxi Wang, Zijia Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115800-115800
Closed Access | Times Cited: 10
Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells
Ting Zhang, Changhua Zhou, Mengfan Lv, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 194, pp. 106706-106706
Open Access | Times Cited: 3
Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR/HER2 inhibition: Cell cycle analysis and in silico study
Dina I. A. Othman, Abdelrahman Hamdi, Walaa M. El-Husseiny, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 11, pp. 101803-101803
Open Access | Times Cited: 8
Targeting Transcriptional CDKs 7, 8, and 9 with Anilinopyrimidine Derivatives as Anticancer Agents: Design, Synthesis, Biological Evaluation and In Silico Studies
Razan Eskandrani, Lamees S. Al-Rasheed, Siddique Akber Ansari, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4271-4271
Open Access | Times Cited: 7
Design, synthesis, and carbonic anhydrase inhibition activities of Schiff bases incorporating benzenesulfonamide scaffold: Molecular docking application
Adel S. El‐Azab, Alaa A.‐M. Abdel‐Aziz, Silvia Bua, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 12, pp. 101866-101866
Open Access | Times Cited: 7
In-silico Binding, Stability, Pharmacokinetics, and Toxicity Studies on Natural (-)-ambrox Metabolites as Binding Ligands to Luminal B and Triple-negative/basal-like Proteins for Breast Cancer Therapy
Abdullah Haikal, Neelaveni Thangavel, Mohammed Albratty, et al.
Letters in Drug Design & Discovery (2024) Vol. 21, Iss. 9, pp. 1569-1581
Closed Access | Times Cited: 1
Design, Synthesis, and Characterization of Novel Thiazolidine-2,4-Dione-Acridine Hybrids as Antitumor Agents
Monika Garberová, Z Kudlicková, Radka Michalková, et al.
Molecules (2024) Vol. 29, Iss. 14, pp. 3387-3387
Open Access | Times Cited: 1
Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors
Mohammad M. Al‐Sanea, Hani M. Hafez, Ahmed A. B. Mohamed, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5109-5127
Open Access | Times Cited: 1
AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans
Israa M. Shamkh, Mahmoud Elkazzaz, Enas S. Radwan, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 34, pp. 2752-2762
Closed Access | Times Cited: 2
Design, synthesis, and in vitro biological evaluation of novel HDAC inhibitors bearing C-1 phenyl substituted tetrahydroisoquinoline Cap moiety as anti-tumor therapeutic agents
Jie Wang, Chi Zhou, Bo Li, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 4, pp. 687-702
Closed Access
Chitosan-enclosed SLN improved SV-induced hepatocellular cell carcinoma death by modulation of IQGAP gene expression, JNK, and HDAC activities
Gamaleldin I. Harisa, Ahmed H. Bakheit, Samiyah Alshehri, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
Structure-forming non-covalent bonding of new 2-(4-carboxyphenylhydrazinylidene)[1,3]thiazolo[3,2-a]pyrimidines in the crystalline phase
Artem S. Agarkov, Dilyara O. Mingazhetdinova, Anna A. Nefedova, et al.
Russian Chemical Bulletin (2024) Vol. 73, Iss. 8, pp. 2350-2369
Closed Access
Synthesis, Biological Evaluation and in Silico Studies of Novel Urea/Thiourea Derivatives of Lenalidomide
Fatih Tok, Burçin İrem Abas, Faika Başoğlu, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 12
Closed Access
Oleic acid and linoleic acid nanosomes boost immunity and provoke cell death via the upregulation of beta-defensin-4 at genetic and epigenetic levels
Gamaleldin I. Harisa, Ibrahim Najashi, Ahmed H. Bakheit, et al.
Open Chemistry (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top